Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Former FBI Director Robert Mueller has Parkinson’s disease:...
Earthwise Advertising & Investor Awareness Campaign
Commencement of Henbury Field Program
RCM to Acquire Webbs Consol Silver Project from...
Basin Energy
Epstein estate to hand over ‘birthday book’ to...
Dyan Cannon denied White House entry after lying...
Israel eliminates Houthi prime minister in Yemen airstrike...
Sen. Bernie Sanders calls on RFK Jr. to...
Trump appointee exits US foreign aid agency after...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Investing

Mernova Q3 Revenue Update

by admin July 24, 2024
July 24, 2024
Mernova Q3 Revenue Update

Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) is pleased to advise that its wholly owned Canadian subsidiary, Mernova, has delivered a strong start to Q3 2024 – amassing confirmed purchase orders of $1.5m (C$1.4m) in Q3 to date. During Q2 of 2024, Mernova had confirmed unaudited purchase orders of $2.0m (C$1.8m). This figure is a 25% increase on Q1 2024 ($1.6m) and a 33% increase on Q2 2023 ($1.5m). During H1 2024, Mernova revenues supported group revenues of $9.2m, a 31% increase on H1 2023 and an annualised rate of $18.4m.

Highlights:

$1.5m (C$1.4m) in confirmed purchase orders for delivery in Q3 2024, a very strong start to the quarterFollows Q2 2024 unaudited confirmed purchase orders total $2.0m (C$1.8m), a 25% increase on Q1 2024 ($1.6m), and a 33% increase on Q2 2023 ($1.5m)Demand underpinned by ongoing emergence of Ritual brand as a high quality option for consumersFollowing recently announced $12m asset sale to strengthen balance sheet, Melodiol to leverage the brand awareness of Ritual to pursue continued sales into Canadian market, either by searching for new facility options or sourcing and branded resale of third party productionMernova was a strong contributor to group H1 2024 revenues of $9.2m, a 31% increase on H1 2023 and annualised rate of $18.4m

As recently announced (refer to ASX release: 23 July 2024), the Company has entered into a non-binding LOI for the sale of the Mernova land and production facility for an initial cash consideration of $12m, with up to $2.2m in earn outs. The transaction consideration is sufficient to repay the Company’s existing secured debt, thereby strengthening the balance sheet and providing working capital for further growth at Health House and Creso Pharma Switzerland. Additionally, the Company will attempt to recuperate revenues from Mernova, by retaining the Ritual brand as part of the transaction and either searching for new facility options, or by leveraging third party production to continue selling into existing markets. Recent revenue results for Mernova show that the Ritual brand experiences strong demand in the market, and the Company intends to leverage this demand during the next phase of its growth.

Management commentary:

CEO and Managing Director, Mr William Lay said: “Mernova continues to deliver very strong sales results. This is a result of the high-quality products that are produced, and the awareness of the brand in its core markets. Despite the contemplated asset sale, we intend to make every effort to continue offering the Ritual brand via either a new facility, or via third party production.”

Click here for the full ASX Release

This post appeared first on investingnews.com

previous post
Production Ramp-Up Proceeding to Plan with Technology Proven at Commercial Scale
next post
Biden’s reported support for SCOTUS term limits poses ‘grave threat to democracy’: experts

You may also like

Fortune Minerals Provides an Update of NICO Project...

January 9, 2025

5 Best-performing Copper Stocks on the TSX in...

April 23, 2025

Enbridge to Expand Gulf of Mexico Presence with...

October 6, 2024

Brunswick Exploration

October 1, 2024

Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech...

November 13, 2024

Zodiac Gold Terminates Exclusivity Agreement with Mable and...

November 20, 2024

Alvopetro Announces Q2 2025 Financial Results and an...

August 7, 2025

Fed Cuts Rate in Post-Election Meeting, Gold and...

November 8, 2024

Earthwise Minerals Completes Phase 1 Field Program at...

August 26, 2025

Pinnacle Silver and Gold

August 21, 2025

Recent Posts

  • Former FBI Director Robert Mueller has Parkinson’s disease: report
  • Earthwise Advertising & Investor Awareness Campaign
  • Commencement of Henbury Field Program
  • RCM to Acquire Webbs Consol Silver Project from Lode Res.
  • Basin Energy

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (902)
    • Investing (2,872)
    • Politics (3,525)
    • Stock (4)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 Sightful Invest. All Rights Reserved.